London, UK and Melbourne, Australia, 30 October 2018 – BioScience Managers Limited (BioScience Managers), the international healthcare investment firm today announces the appointment of Dr. Kate Rowley as Investment Director, based in London. Reflecting BioScience Managers’ international focus Dr. Rowley’s role will be to review and evaluate healthcare investment opportunities and manage investment deals from […]
By Christine Hall | September 12, 2018 The Texas Medical Center and the Department for International Trade in the United Kingdom formed a landmark BioBridge agreement Wednesday to provide a gateway for the advancement of life sciences between the two entities in the areas of innovation and research. The BioBridge, which included more than 18 months of preparation […]
Valencia, Calif., USA, and Melbourne, Australia, 28 June 2018 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that it has entered into an agreement to acquire a manufacturing facility to support the planned U.S. launch of the RECELL® Autologous Cell Harvesting Device in the treatment of burns. The facility is currently operated by a […]
PUBLIC COMPANY INFORMATION: “Furthermore, treatment with AB-PA01 was safe and well-tolerated. In this case study, bacteriophage therapy has demonstrated to hold much promise for patients with cystic fibrosis suffering from multidrug resistant pulmonary bacterial infections.” AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today […]
Destiny Pharma has a Scientific Advisory Board (SAB) of key opinion leaders in relevant fields to help guide and inform the future clinical development of the XF platform. Our SAB includes the following members: David Roblin MD FRCP FFPM FMedSci (SAB Chairman) Professor David Roblin is President of Research and Development at Summit Therapeutics. David […]
riday, May 18, 2018 6:50 am EDT SAN DIEGO PUBLIC COMPANY INFORMATION: “We are delighted to participate in TID 2018 and to share our product development experience and clinical perspective on the promise of phage therapeutics as a potential treatment for combatting increasing, and potentially life-threatening, antibiotic resistance” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: […]
18 May 2018 San Mateo, CA – May 18, 2018: Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it’s Hailie™(previously known as Smartinhaler™) technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal […]
17 May 2018 San Mateo, CA – May 16th, 2018: Adherium (ASX: ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the Hailie™ global brand to connect people with asthma and COPD to better care. The launch is a rebrand of the existing Smartinhaler™ brand, and […]
Announced positive topline results for the initial seven patients treated with AB-SA01 or AB-PA01 under ongoing expanded access program and presented detailed results for the first patient at a medical conference Signed collaborative agreements with the U.S. Department of Veterans Affairs and the Westmead Hospital in Sydney Completed two financings for combined gross proceeds of […]
When is World No Tobacco Day? World No Tobacco Day takes place annually on May 31. What is the reason for World No Tobacco Day? World No Tobacco Day is an annual awareness day sponsored by the World Health Organization (WHO) since 1987 to highlight the health risks associated with tobacco use and encourage governments to […]